Log In
Print
BCIQ
Print
Print this Print this
 

Suboxone, buprenorphine/naloxone

  Manage Alerts
Collapse Summary General Information
Company Reckitt Benckiser Group plc
DescriptionBuprenorphine and naloxone tablet
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat opiate dependency
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today